Ophthalmic Cons of Long Island is a clinical research site located in Oceanside, New York, United States 11572.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Ophthalmic Cons of Long Island has participated in 4 clinical trials.
Therapeutic areas: Wet Macular Degeneration, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.
Sponsors: Hoffmann-La Roche.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Oceanside
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ophthalmic Cons of Long Island has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ophthalmic Cons of Long Island has 4 clinical trials on record. Their work covers Wet Macular Degeneration, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.
Ophthalmic Cons of Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.